Anzeige
Mehr »
Freitag, 27.06.2025 - Börsentäglich über 12.000 News
Blockbuster-Bohrergebnisse: Gold-Antimon-Fund in Nevada trifft geopolitischen Nerv
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3EWWY | ISIN: US92859E2072 | Ticker-Symbol:
NASDAQ
26.06.25 | 21:59
3,380 US-Dollar
0,00 % 0,000
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
VIVOS THERAPEUTICS INC Chart 1 Jahr
5-Tage-Chart
VIVOS THERAPEUTICS INC 5-Tage-Chart

Aktuelle News zur VIVOS THERAPEUTICS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DoVivos Therapeutics Stock Climbs 9% On Positive Pediatric Sleep Apnea Study-
DoVivos Therapeutics, Inc: New Clinical Trial Data Published Showing Positive Results from Use of Vivos Technology to Treat Obstructive Sleep Apnea in Children1
11.06.Vivos Therapeutics Finalizes Acquisition Of The Sleep Center Of Nevada1
11.06.Vivos Therapeutics, Inc: Vivos Therapeutics Completes Acquisition of The Sleep Center of Nevada145Transaction brings OSA diagnostic revenue to Vivos, plus Vivos' highly effective OSA treatment options to thousands of potential patients in the greater Las Vegas area Transaction also completes...
► Artikel lesen
06.06.Vivos Therapeutics ernennt Baker Tilly nach Fusion zum neuen Wirtschaftsprüfer1
06.06.Vivos Therapeutics, Inc. - 8-K, Current Report2
23.05.Vivos Therapeutics, Inc. - 8-K, Current Report1
16.05.Vivos Therapeutics GAAP EPS of -$0.45 misses by $0.10, revenue of $3.02M misses by $1.18M3
VIVOS THERAPEUTICS Aktie jetzt für 0€ handeln
16.05.Vivos Therapeutics signals transformative growth with SCN acquisition and expects positive cash flow by end of 20251
15.05.Vivos Therapeutics, Inc. - 8-K, Current Report2
15.05.Vivos Therapeutics, Inc: Vivos Therapeutics Reports First Quarter 2025 Financial Results and Provides Operational Update136Year-over-year product revenue increased 8%, and year-over-year operating expenses decreased 5% as Vivos sets the stage for its Sleep Center of Nevada acquisition and continued advancement of its...
► Artikel lesen
17.04.Vivos Therapeutics, Inc. - 8-K, Current Report3
16.04.Vivos Therapeutics to acquire operating assets of The Sleep Center of Nevada1
16.04.Vivos Therapeutics, Inc: Vivos Therapeutics Signs Definitive Agreement to Acquire Largest Sleep Center Operator in Nevada113By acquiring The Sleep Center of Nevada, Vivos expands its business model to make its OSA treatments available to thousands of patients in the greater Las Vegas metro area Acquisition expected to...
► Artikel lesen
31.03.Vivos Therapeutics, Inc. - 8-K, Current Report1
31.03.Vivos Therapeutics GAAP EPS of -$2.22 misses by $0.20, revenue of $15.03M misses by $0.17M5
31.03.Vivos Therapeutics, Inc: Vivos Therapeutics Reports Full Year 2024 Financial Results and Provides Operational Update91Year over year product revenue increased 26% Operating expenses declined 21% and year over year operating loss decreased 35% Management to Host Conference Call today at 5:00 pm ET LITTLETON, Colo....
► Artikel lesen
31.03.Vivos Therapeutics, Inc. - 10-K, Annual Report3
28.03.Earnings Outlook For Vivos Therapeutics2
18.02.Vivos Therapeutics, Inc: Vivos Therapeutics to Participate in Fireside Chat with Water Tower Research on February 18, 2025 at 12:00 pm ET.1
Weiter >>
30 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1